Bodurka DC - Search Results

1

Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.

Litton JK, Westin SN, Ready K, Sun CC, Peterson SK, Meric-Bernstam F, Gonzalez-Angulo AM, Bodurka DC, Lu KH, Hortobagyi GN, Arun BK. Litton JK, et al. Among authors: bodurka dc. Cancer. 2009 Apr 15;115(8):1598-604. doi: 10.1002/cncr.24199. Cancer. 2009. PMID: 19280625 Free PMC article.

2

Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?

Sun CC, Bodurka DC, Donato ML, Rubenstein EB, Borden CL, Basen-Engquist K, Munsell MF, Kavanagh JJ, Gershenson DM. Sun CC, et al. Among authors: bodurka dc. Gynecol Oncol. 2002 Oct;87(1):118-28. doi: 10.1006/gyno.2002.6807. Gynecol Oncol. 2002. PMID: 12468352

3

beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma.

Lee CM, Shvartsman H, Deavers MT, Wang SC, Xia W, Schmandt R, Bodurka DC, Atkinson EN, Malpica A, Gershenson DM, Hung MC, Lu KH. Lee CM, et al. Among authors: bodurka dc. Gynecol Oncol. 2003 Mar;88(3):363-8. doi: 10.1016/s0090-8258(02)00015-x. Gynecol Oncol. 2003. PMID: 12648588

4

Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.

Schmandt RE, Broaddus R, Lu KH, Shvartsman H, Thornton A, Malpica A, Sun C, Bodurka DC, Gershenson DM. Schmandt RE, et al. Among authors: bodurka dc. Cancer. 2003 Aug 15;98(4):758-64. doi: 10.1002/cncr.11561. Cancer. 2003. PMID: 12910520 Free article.

5

Cervical cancer.

Basen-Engquist K, Paskett ED, Buzaglo J, Miller SM, Schover L, Wenzel LB, Bodurka DC. Basen-Engquist K, et al. Among authors: bodurka dc. Cancer. 2003 Nov 1;98(9 Suppl):2009-14. doi: 10.1002/cncr.11681. Cancer. 2003. PMID: 14603537 Free article. Review.

6

Vacuum-assisted closure in the treatment of gynecologic oncology wound failures.

Schimp VL, Worley C, Brunello S, Levenback CC, Wolf JK, Sun CC, Bodurka DC, Ramirez PT. Schimp VL, et al. Among authors: bodurka dc. Gynecol Oncol. 2004 Feb;92(2):586-91. doi: 10.1016/j.ygyno.2003.10.055. Gynecol Oncol. 2004. PMID: 14766251

7

An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies.

Navo MA, Phan J, Vaughan C, Palmer JL, Michaud L, Jones KL, Bodurka DC, Basen-Engquist K, Hortobagyi GN, Kavanagh JJ, Smith JA. Navo MA, et al. Among authors: bodurka dc. J Clin Oncol. 2004 Feb 15;22(4):671-7. doi: 10.1200/JCO.2004.04.162. J Clin Oncol. 2004. PMID: 14966090

8

Grading ovarian serous carcinoma using a two-tier system.

Malpica A, Deavers MT, Lu K, Bodurka DC, Atkinson EN, Gershenson DM, Silva EG. Malpica A, et al. Among authors: bodurka dc. Am J Surg Pathol. 2004 Apr;28(4):496-504. doi: 10.1097/00000478-200404000-00009. Am J Surg Pathol. 2004. PMID: 15087669

9

Evaluation of patient chemotherapy education in a gynecology oncology center.

Smith JA, Kindo CC, Kurian S, Whitaker LM, Burke C, Wachel B, Sun CC, Weaver CL, Danielson MG, Fitzgerald MA, Munsell M, Zandstra FA, Bodurka DC. Smith JA, et al. Among authors: bodurka dc. Support Care Cancer. 2004 Aug;12(8):577-83. doi: 10.1007/s00520-003-0546-5. Epub 2004 May 28. Support Care Cancer. 2004. PMID: 15168104

10

Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?

Slomovitz BM, Sun CC, Ramirez PT, Bodurka DC, Diaz P, Lu KH. Slomovitz BM, et al. Among authors: bodurka dc. Obstet Gynecol. 2004 Aug;104(2):255-60. doi: 10.1097/01.AOG.0000131620.67911.03. Obstet Gynecol. 2004. PMID: 15291996

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters